Ekf Diagnostics Stock Price, News & Analysis (LON:EKF)

GBX 26 -0.25 (-0.95 %)
(As of 12/11/2017 02:46 AM ET)
Previous CloseGBX 26.25
Today's RangeGBX 25.50 - GBX 26.25
52-Week RangeGBX 15.56 - GBX 27.69
VolumeN/A
Average Volume661,229 shs
Market Capitalization£120.71 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Ekf Diagnostics (LON:EKF)

Ekf Diagnostics logoEKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. The Company's Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen C-Line and Biosen S-Line, STAT-Site M B-HB analyzer, sTNFR1 biomarker test kits and Altair 240.

Receive EKF News and Ratings via Email

Sign-up to receive the latest news and ratings for EKF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Monitoring Systems
Sub-IndustryN/A
SectorHealthcare
SymbolLON:EKF
CUSIPN/A
Phone+44-29-20710570

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net Margins-0.93%
Return on Equity-0.90%
Return on Assets-0.49%

Miscellaneous

EmployeesN/A
Outstanding Shares457,630,000

Ekf Diagnostics (LON:EKF) Frequently Asked Questions

What is Ekf Diagnostics' stock symbol?

Ekf Diagnostics trades on the London Stock Exchange (LON) under the ticker symbol "EKF."

Where is Ekf Diagnostics' stock going? Where will Ekf Diagnostics' stock price be in 2017?

1 Wall Street analysts have issued 1-year target prices for Ekf Diagnostics' shares. Their predictions range from GBX 21 to GBX 21. On average, they anticipate Ekf Diagnostics' share price to reach GBX 21 in the next year. View Analyst Ratings for Ekf Diagnostics.

Who are some of Ekf Diagnostics' key competitors?

Who are Ekf Diagnostics' key executives?

Ekf Diagnostics' management team includes the folowing people:

  • Julian Huw Baines, Chief Executive Officer, Executive Director (Age 50)
  • Richard Anthony Evans, Finance Director, Chief Operating Officer, Executive Director (Age 57)
  • Christopher Harwood Bernard Mills, Non-Executive Chairman of the Board (Age 64)
  • David Eric Evans, Non-Executive Deputy Chairman of the Board
  • Carl Dominic Contadini, Non-Executive Director (Age 67)
  • Adam Reynolds, Independent Non-Executive Director (Age 53)

How do I buy Ekf Diagnostics stock?

Shares of Ekf Diagnostics and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Ekf Diagnostics' stock price today?

One share of Ekf Diagnostics stock can currently be purchased for approximately GBX 26.

How big of a company is Ekf Diagnostics?

Ekf Diagnostics has a market capitalization of £120.71 million.

How can I contact Ekf Diagnostics?

Ekf Diagnostics' mailing address is Avon HSE, 19 Stanwell Road, PENARTH, CF64 2EZ, United Kingdom. The company can be reached via phone at +44-29-20710570.


MarketBeat Community Rating for Ekf Diagnostics (EKF)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  237 (Vote Outperform)
Underperform Votes:  110 (Vote Underperform)
Total Votes:  347
MarketBeat's community ratings are surveys of what our community members think about Ekf Diagnostics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Ekf Diagnostics (LON:EKF) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.502.502.503.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 20GBX 20GBX 20GBX 20

Ekf Diagnostics (LON:EKF) Consensus Price Target History

Price Target History for Ekf Diagnostics (LON:EKF)

Ekf Diagnostics (LON:EKF) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
9/6/2017Panmure GordonReiterated RatingHoldView Rating Details
7/6/2017N+1 SingerReiterated RatingcorporateView Rating Details
11/29/2016FinnCapReiterated RatingUnder ReviewView Rating Details
(Data available from 12/11/2015 forward)

Earnings

Earnings History for Ekf Diagnostics (LON:EKF)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Ekf Diagnostics (LON:EKF) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Ekf Diagnostics (LON:EKF)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Ekf Diagnostics (LON EKF) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Ekf Diagnostics (LON:EKF)

Ekf Diagnostics (LON EKF) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/3/2017Christopher H B MillsInsiderSell1,000,000GBX 24£240,000
3/20/2017Christopher H B MillsInsiderBuy8,000,000GBX 19£1,520,000
7/15/2016Mills,Christopher H BInsiderBuy9,000,000GBX 15£1,350,000
6/24/2016Mills,Christopher H BInsiderBuy2,613,957GBX 12£313,674.84
6/23/2016Mills,Christopher H BInsiderBuy2,000,000GBX 12£240,000
6/21/2016Mills,Christopher H BInsiderBuy4,500,000GBX 12£540,000
6/17/2016Mills,Christopher H BInsiderBuy532,781GBX 12£63,933.72
6/9/2016Mills,Christopher H BInsiderBuy447,666GBX 12£53,719.92
(Data available from 1/1/2013 forward)

Headlines

Ekf Diagnostics (LON EKF) News Headlines

Source:
DateHeadline
EKF Diagnostics Holdings Plc breached its 50 day moving average in a Bearish Manner : EKF-GB : December 1, 2017EKF Diagnostics Holdings Plc breached its 50 day moving average in a Bearish Manner : EKF-GB : December 1, 2017
finance.yahoo.com - December 1 at 5:16 PM
EKF Diagnostics Holdings Plc :EKF-GB: Earnings Analysis: For the six months ended June 30, 2017 : November 9, 2017EKF Diagnostics Holdings Plc :EKF-GB: Earnings Analysis: For the six months ended June 30, 2017 : November 9, 2017
finance.yahoo.com - November 10 at 12:03 PM
EKF Diagnostics Holdings Plc breached its 50 day moving average in a Bearish Manner : EKF-GB : October 25, 2017EKF Diagnostics Holdings Plc breached its 50 day moving average in a Bearish Manner : EKF-GB : October 25, 2017
finance.yahoo.com - October 25 at 8:01 PM
Cancellation of escrow shares PDMR dealing/buyback - London South East (blog)Cancellation of escrow shares PDMR dealing/buyback - London South East (blog)
www.lse.co.uk - October 5 at 5:26 PM
EKF Diagnostics Holdings Plc – Value Analysis (LONDON:EKF) : October 5, 2017EKF Diagnostics Holdings Plc – Value Analysis (LONDON:EKF) : October 5, 2017
finance.yahoo.com - October 5 at 5:26 PM
Christopher H. B. Mills Sells 1,000,000 Shares of Ekf Diagnostics Holding PLC (EKF) StockChristopher H. B. Mills Sells 1,000,000 Shares of Ekf Diagnostics Holding PLC (EKF) Stock
www.americanbankingnews.com - October 4 at 10:42 AM
EKF Diagnostics Holdings Plc breached its 50 day moving average in a Bullish Manner : EKF-GB : October 4, 2017EKF Diagnostics Holdings Plc breached its 50 day moving average in a Bullish Manner : EKF-GB : October 4, 2017
finance.yahoo.com - October 4 at 10:17 AM
EKF Diagnostics Holdings Plc breached its 50 day moving average in a Bearish Manner : EKF-GB : September 19, 2017EKF Diagnostics Holdings Plc breached its 50 day moving average in a Bearish Manner : EKF-GB : September 19, 2017
finance.yahoo.com - September 19 at 6:13 PM
EKF Diagnostics Trading In Line As It Swings To Interim ProfitEKF Diagnostics Trading In Line As It Swings To Interim Profit
www.morningstar.co.uk - September 13 at 12:01 AM
EKF Diagnostics Trading In Line As It Swings To Interim Profit - London South East (registration) (blog)EKF Diagnostics Trading In Line As It Swings To Interim Profit - London South East (registration) (blog)
www.lse.co.uk - September 11 at 11:48 PM
Ekf Diagnostics Holding PLC (EKF) Receives Hold Rating from Panmure GordonEkf Diagnostics Holding PLC (EKF) Receives Hold Rating from Panmure Gordon
www.americanbankingnews.com - September 6 at 7:20 AM
Ekf Diagnostics Holding PLC (EKF) Scheduled to Post Quarterly Earnings on MondayEkf Diagnostics Holding PLC (EKF) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - September 4 at 2:23 AM
3 Hot Shares That Might Take Off In September3 Hot Shares That Might Take Off In September
finance.yahoo.com - September 1 at 6:33 PM
Ekf Diagnostics Holding PLCs (EKF) corporate Rating Reiterated at N+1 SingerEkf Diagnostics Holding PLC's (EKF) corporate Rating Reiterated at N+1 Singer
www.americanbankingnews.com - July 9 at 7:30 AM
EKF Diagnostics Expects Full-Year Results Ahead Of Market ForecastsEKF Diagnostics Expects Full-Year Results Ahead Of Market Forecasts
www.morningstar.co.uk - July 7 at 5:31 AM
EKF Diagnostics Sees FY Adj EBITDA Ahead Of Market View; Stock UpEKF Diagnostics Sees FY Adj EBITDA Ahead Of Market View; Stock Up
www.rttnews.com - July 7 at 5:31 AM
Cancellation of share options - London South East (registration) (blog)Cancellation of share options - London South East (registration) (blog)
www.lse.co.uk - June 28 at 3:14 AM
Hygea VCT plc : Update for the quarter ended 31 March 2017 - GlobeNewswire (press release)Hygea VCT plc : Update for the quarter ended 31 March 2017 - GlobeNewswire (press release)
globenewswire.com - May 19 at 8:05 AM
EKF Diagnostics Optimistic, Still Considering Potential Demerger - London South East (registration) (blog)EKF Diagnostics Optimistic, Still Considering Potential Demerger - London South East (registration) (blog)
www.lse.co.uk - May 11 at 5:35 PM
Hygea VCT plc : Annual Report and Accounts and Notice of AGMHygea VCT plc : Annual Report and Accounts and Notice of AGM
globenewswire.com - April 10 at 4:43 PM
The Top 50 Manufacturers of Hematology In-Vitro Diagnostics Analyzers, Reagents & Accessories WorldwideThe Top 50 Manufacturers of Hematology In-Vitro Diagnostics Analyzers, Reagents & Accessories Worldwide
www.prnewswire.com - March 29 at 11:37 AM
Full Year 2016 EKF Diagnostics Holdings PLC Earnings Release - Before Market OpenFull Year 2016 EKF Diagnostics Holdings PLC Earnings Release - Before Market Open
biz.yahoo.com - March 20 at 7:39 PM
This ‘special situation’ stock looks set to flyThis ‘special situation’ stock looks set to fly
uk.finance.yahoo.com - March 20 at 7:39 PM
Global Diabetes Diagnostics Industry - PR Newswire (press release)Global Diabetes Diagnostics Industry - PR Newswire (press release)
www.prnewswire.com - February 28 at 5:07 PM
EKF Diagnostics 2016 Revenue Outpaces Previous GuidanceEKF Diagnostics 2016 Revenue Outpaces Previous Guidance
www.morningstar.co.uk - January 9 at 5:45 PM
Does EKF Diagnostics Holding plc have more upside than GlaxoSmithKline plc after beating expectations?Does EKF Diagnostics Holding plc have more upside than GlaxoSmithKline plc after beating expectations?
uk.finance.yahoo.com - January 9 at 5:45 PM
EKF Diagnostics FY16 Overall Performance To Exceed Revised Market ForecastsEKF Diagnostics FY16 Overall Performance To Exceed Revised Market Forecasts
www.rttnews.com - January 9 at 2:46 AM
Oryx International Growth Fund Net Assets Beat Benchmark In - London South East (registration) (blog)Oryx International Growth Fund Net Assets Beat Benchmark In - London South East (registration) (blog)
www.lse.co.uk - December 14 at 5:56 PM
EKF Diagnostics Sees FY Results To Exceed Market View; Stock ClimbsEKF Diagnostics Sees FY Results To Exceed Market View; Stock Climbs
www.rttnews.com - October 7 at 4:44 PM
Is Ekf Diagnostics Holding plc a buy as shares jump 10%+?Is Ekf Diagnostics Holding plc a buy as shares jump 10%+?
uk.finance.yahoo.com - October 7 at 9:46 AM

SEC Filings

Ekf Diagnostics (LON:EKF) SEC Filings

DateFilerForm TypeView

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Ekf Diagnostics (LON EKF) Stock Chart for Monday, December, 11, 2017

Loading chart…

This page was last updated on 12/11/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.